| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-08-3053 |
| P698 | PubMed publication ID | 19509158 |
| P2093 | author name string | Mei Yang | |
| Donghui Wu | |||
| Jinsong Li | |||
| Weiliang Chen | |||
| Zhaoyu Lin | |||
| Erwei Song | |||
| Lijuan Sun | |||
| Hongzhang Huang | |||
| Peter Zhang | |||
| Chunxian Zeng | |||
| Yandan Yao | |||
| Chaobin Pan | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 3998-4008 | |
| P577 | publication date | 2009-06-09 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor | |
| P478 | volume | 15 |
| Q47800026 | A Looking-Glass of Non-coding RNAs in oral cancer |
| Q38781631 | A panel of microRNAs can be used to determine oral squamous cell carcinoma. |
| Q34443746 | Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene |
| Q37328429 | Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value |
| Q26998025 | Alterations of microRNAs contribute to colon carcinogenesis |
| Q38931476 | Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics |
| Q38931231 | Altering β-cell number through stable alteration of miR-21 and miR-34a expression |
| Q38346601 | Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells |
| Q28710308 | Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges |
| Q92840133 | Circular RNAs: Diversity of Functions and a Regulatory Nova in Oral Medicine: A Pilot Review |
| Q37543840 | Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children |
| Q91895987 | Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis |
| Q54300178 | Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. |
| Q37702686 | Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. |
| Q54193247 | Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. |
| Q36286699 | Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients |
| Q38944423 | Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas |
| Q37970449 | Current trends in miRNAs and their relationship with oral squamous cell carcinoma. |
| Q39097075 | Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42. |
| Q54305467 | Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck. |
| Q34310243 | Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer |
| Q37204742 | Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients |
| Q24600829 | Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma |
| Q58614528 | Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis |
| Q36598489 | Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS. |
| Q41398822 | Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer |
| Q64921210 | Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3. |
| Q36446991 | Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer |
| Q46434900 | Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. |
| Q37853945 | Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review |
| Q36602726 | Epigenetic mechanisms in oral carcinogenesis. |
| Q54339320 | Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. |
| Q53078040 | Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. |
| Q61797406 | Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery |
| Q36628349 | Genome-wide approaches (GWA) in oral and craniofacial diseases research |
| Q34385121 | HIF-1α regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft model |
| Q24569637 | High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients |
| Q37626488 | High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer |
| Q41733564 | Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma |
| Q33903223 | Implication of microRNAs in drug resistance for designing novel cancer therapy |
| Q38755836 | Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods |
| Q35080717 | Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma |
| Q47142032 | Increased precursor microRNA-21 following status epilepticus can compete with mature microRNA-21 to alter translation |
| Q33575734 | Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways |
| Q48231582 | Integrated miRNA-mRNA spatial signature for oral squamous cell carcinoma: a prospective profiling study of Narrow Band Imaging guided resection. |
| Q33591763 | Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma |
| Q92287797 | Ionizing Radiation-inducible microRNA-21 Induces Angiogenesis by Directly Targeting PTEN |
| Q35742729 | KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation |
| Q36215892 | Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. |
| Q88874175 | Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p |
| Q38779984 | MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer |
| Q41548123 | Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms |
| Q37806613 | Metastamirs: a stepping stone towards improved cancer management |
| Q35302023 | MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer |
| Q39513672 | MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. |
| Q37706078 | MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol |
| Q46677764 | MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. |
| Q35155103 | MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival |
| Q53694673 | MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1. |
| Q39017248 | MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. |
| Q35853982 | MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1 |
| Q47133718 | MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2. |
| Q35579040 | MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. |
| Q58605714 | MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis |
| Q41830881 | MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1. |
| Q38178272 | MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas |
| Q34725426 | MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma |
| Q38017596 | MicroRNA control of epithelial-mesenchymal transition and metastasis. |
| Q27305161 | MicroRNA dysregulation in the spinal cord following traumatic injury |
| Q34268278 | MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma |
| Q26779540 | MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma |
| Q53226065 | MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma. |
| Q49418603 | MicroRNA expression in patients with squamous cell carcinoma of the tongue |
| Q92248266 | MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer |
| Q27001048 | MicroRNA in cancer: new hopes for antineoplastic chemotherapy |
| Q54424273 | MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. |
| Q36863089 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma |
| Q49690867 | MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma |
| Q53290459 | MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. |
| Q92644695 | MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma |
| Q26851333 | MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis |
| Q39630445 | MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. |
| Q39359970 | MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide |
| Q38180409 | MicroRNA-21 is a novel promising target in cancer radiation therapy |
| Q92723931 | MicroRNA-21 over expression in umbilical cord blood hematopoietic stem progenitor cells by leukemia microvesicles |
| Q34426103 | MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration |
| Q39100944 | MicroRNA-21 promotes oral cancer invasion via the Wnt/β-catenin pathway by targeting DKK2. |
| Q36113576 | MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma |
| Q27853222 | MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. |
| Q38604500 | MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway |
| Q92354882 | MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin |
| Q37046669 | MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway |
| Q39076246 | MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway |
| Q27024066 | MicroRNAs - Biology and clinical applications |
| Q36116268 | MicroRNAs and cancer therapeutics |
| Q26778591 | MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis |
| Q37292279 | MicroRNAs in Head and Neck Cancer |
| Q38166570 | MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC). |
| Q37968114 | MicroRNAs in an oral cancer context - from basic biology to clinical utility |
| Q38057979 | MicroRNAs in cancer diagnosis and therapy: from bench to bedside |
| Q38199556 | MicroRNAs in the Regulation of MMPs and Metastasis |
| Q33942272 | MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. |
| Q38855825 | MicroRNA‑197 reverses the drug resistance of fluorouracil‑induced SGC7901 cells by targeting mitogen‑activated protein kinase 1 |
| Q34108602 | Micromarkers: miRNAs in cancer diagnosis and prognosis. |
| Q42215256 | Modulation of chemoresponsiveness to platinum-based agents by microRNAs in cancer |
| Q49525017 | Molecular Simulation Studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist |
| Q34177065 | Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer |
| Q38586823 | Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges |
| Q34130311 | OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. |
| Q35673572 | Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment |
| Q24632574 | Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells |
| Q39345110 | Overexpression of interleukin-18 induces growth inhibition, apoptosis and gene expression changes in a human tongue squamous cell carcinoma cell line |
| Q38779461 | Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression |
| Q48051499 | Plasma miR-187* is a potential biomarker for oral carcinoma |
| Q37394399 | Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients |
| Q39104168 | Plumbagin induces the apoptosis of human tongue carcinoma cells through the mitochondria-mediated pathway |
| Q37705222 | Potential role of micro-RNAs in head and neck tumorigenesis. |
| Q92210309 | Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis |
| Q34602432 | Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma |
| Q38120287 | Prognostic molecular markers in cancer - quo vadis? |
| Q33899211 | Prognostic value of miR-21 in various cancers: an updating meta-analysis |
| Q34420611 | Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma. |
| Q34019798 | Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro |
| Q27026972 | Regulating miRNA by natural agents as a new strategy for cancer treatment |
| Q35034340 | Regulation of cancer metastasis by cell-free miRNAs |
| Q34283589 | Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research |
| Q35921160 | Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers. |
| Q35956619 | Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells |
| Q33850064 | Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators |
| Q37454682 | Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II. |
| Q39628381 | Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma |
| Q48301918 | Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review. |
| Q90747242 | Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population |
| Q89014920 | Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review |
| Q26825764 | Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy |
| Q37687634 | Single nucleotide polymorphisms in microRNA genes are associated with cervical cancer susceptibility in a population from Xinjiang Uygur |
| Q33780712 | Strengths and limitations of laboratory procedures for microRNA detection |
| Q42022792 | Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. |
| Q39370408 | Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer |
| Q38848171 | Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial. |
| Q35652724 | The Anti-Apoptotic Role of Berberine in Preimplantation Embryo In Vitro Development through Regulation of miRNA-21. |
| Q37282902 | The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment |
| Q38620060 | The Role of Wnt Signaling in Squamous Cell Carcinoma |
| Q34525363 | The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma |
| Q36337417 | The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. |
| Q35740111 | The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer |
| Q38170025 | The microRNA networks of TGFβ signaling in cancer |
| Q26851256 | The role of microRNA in head and neck cancer: current knowledge and perspectives |
| Q38400255 | The role of microRNA in nutritional control |
| Q36096641 | The role of microRNAs in colorectal cancer |
| Q40990151 | The role of microRNAs in head and neck squamous cell carcinoma : Biomarkers for prognosis, therapy selection, and novel therapeutics |
| Q38925286 | The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer |
| Q28478758 | Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer |
| Q36275252 | Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma |
| Q34998307 | Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer |
| Q38198988 | Update of molecular pathobiology in oral cancer: a review |
| Q35685531 | Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas |
| Q92491405 | Visualization of mucosal field in HPV positive and negative oropharyngeal squamous cell carcinomas: combined genomic and radiology based 3D model |
| Q39638471 | miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein |
| Q47103533 | miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK. |
| Q58587322 | miR-125a Promotes the Progression of Giant Cell Tumors of Bone by Stimulating IL-17A and β-Catenin Expression |
| Q39032011 | miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells |
| Q34069609 | miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. |
| Q38712802 | miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line |
| Q48017709 | miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients |
| Q34310702 | miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas |
| Q34420624 | miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. |
| Q90448202 | miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma |
| Q54786000 | miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. |
| Q34277279 | miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14. |
| Q37699951 | miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/β-Catenin Pathway in Tongue Squamous Cell Carcinoma. |
| Q35591447 | miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1. |
| Q37577131 | miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma |
| Q53538396 | miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα. |
| Q47599483 | miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway |
| Q38288970 | miR182 activates the Ras-MEK-ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1. |
| Q33530333 | miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines |
| Q26747138 | miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review |
| Q44056340 | microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma |
| Q38521725 | microRNA therapies in cancer |
| Q101410380 | microRNAs deregulation in head and neck squamous cell carcinoma |
| Q39274997 | microRNAs: Emerging players in oral cancers and inflammatory disorders |
Search more.